Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases November 12, 2026 Lineage Cell Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update November 12, 2026 Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s Disease November 05, 2026 Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026 VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview (September 14, 2026) 4.7 MB OpRegen® 3 Year Clinical Data Update (Retinal Innovation Summit 2026) 2.1 MB Roche Pharma Day 2025 Presentation 8.1 MB Third Quarter 2026 Financial Results Earnings Call Nov 12, 2026 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
November 12, 2026 Lineage Cell Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
November 12, 2026 Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s Disease
November 05, 2026 Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
Third Quarter 2026 Financial Results Earnings Call Nov 12, 2026 at 4:30 PM EST Click here for webcast
